Monthly Report - March 2022

Comments:
My overall portfolio ended at a very slight gain of +0.4% in the month of March 2022. The S&P500 gained +3.6% on positive developments of the Russian-Ukraine peace talks. However, the Hang Seng fell -3.2% due to concerns on regulatory risk (delisting) of China shares on the USA exchanges.
    So while my western-related funds like Europe Industrial Stock (+5.7%), TA Global Tech (+2.3%) and United Global (+1.2%) benefited from the S&P500 gains, it was kept in check by the China-related funds like Principal Greater China (-6.0%) and StashAway (-3.0%). StashAway actually reoptimized its portfolio in mid March 2022 to exit all China-related ETF due to China's potential collusion with Russia in its war.
    The rate hike by the US Fed also affected my portfolio. While inflation hedges like the Manulife REIT (+4.7%) went up, my AmBond fund (-0.4%) dipped. The United ASEAN (+0.8%) also did well to outperform the KLCI (-1.3%).
   I had quite a bit an inflow of funds (RM 5,861) this month due to my 2021 tax return. Had to start replenishing my emergency fund (AmBond) after it was drained into home renovations.

Forward Strategy:
United Global Equity has announced a hard closure (no more new money). My new fund flows into the global sector will be heading into Manulife Investment U.S. Equity Fund.
   I will continue to Value Cost Average (VCA) into my funds, keeping them at a fixed weightage as follows; United Global Equity & Manulife US Equity (20.0%), StashAway (20.0%), TA Global Tech (20.0%), Principal Greater China (15.0%), United ASEAN (12.5%) and Manulife REITS (12.5%).